John Luff Selected Research

5- carboxy- 1,1,3,3- tetramethylisoindolin- 2- yloxyl

9/2006

Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John Luff Research Topics

Disease

3	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2019 - 01/2006
3	Neoplasms (Cancer) 01/2017 - 09/2006
2	Inflammation (Inflammations) 12/2019 - 01/2013
1	Neuroinflammatory Diseases 01/2017
1	Atrophy 01/2017
1	Bites and Stings (Sting) 01/2017
1	Paralysis (Palsy) 01/2017
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2006
1	Lymphoma (Lymphomas) 09/2006
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2006

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 12/2019 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2006
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 01/2017
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2019
1	Phosphotransferases (Kinase)IBA 12/2019
1	Ataxia Telangiectasia Mutated ProteinsIBA 01/2017
1	AntioxidantsIBA 09/2006
1	5- carboxy- 1,1,3,3- tetramethylisoindolin- 2- yloxylIBA 09/2006
1	nitroxylIBA 09/2006

Therapy/Procedure

1	Therapeutics 09/2006